NCT02088736

Brief Summary

In patients with out-of-hospital cardiac arrest in Singapore, investigators aim to assess the benefit of introducing a resuscitation protocol including the use of intravenous (IV) access and/or intraosseous (IO) vascular access in the pre-hospital setting. The assumption is that low vascular access rates could be due to difficulty of setting IV cannulas in the field due to certain factors like poor lighting or space constraints. Thus, by introducing a protocol including IO access for difficult IV cases, success rates for vascular access will be higher and this might lead to higher survival rates. This will be a study comparing 'IV+IO' and 'IV alone' protocols in patients with cardiac arrest managed by Singapore Civil Defence Force (SCDF) emergency ambulance service. The trial will recruit 400 patients over 1 year. Each of the 30 SCDF ambulances will provide both 'IV+IO' and 'IV alone' treatments in 2 consecutive phases of 6-months in order to allow for all ambulance crew a chance to be trained on usage of IO. Currently, IO insertion is the accepted standard of care in Singapore General Hospital, Department of Emergency Medicine.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,103

participants targeted

Target at P75+ for phase_4

Timeline
Completed

Started Jun 2014

Typical duration for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 11, 2014

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 17, 2014

Completed
3 months until next milestone

Study Start

First participant enrolled

June 1, 2014

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2017

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2017

Completed
Last Updated

October 28, 2019

Status Verified

October 1, 2019

Enrollment Period

2.6 years

First QC Date

March 11, 2014

Last Update Submit

October 23, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Any Return of Spontaneous Circulation Rate (ROSC)

    Any ROSC including transient or intermittent during pre- or in-hospital

    At scene to hospital (about 2 hours)

Secondary Outcomes (4)

  • Insertion success rate

    90 secs

  • Number of patients administered 1st dose

    90 secs

  • Survival outcome

    up to 30 days

  • Time taken for 1st dose of adrenaline given

    90 secs

Study Arms (2)

Intravenous and Intraosseous

ACTIVE COMPARATOR

'IV + IO' Intravenous fluids or medications needed and a peripheral IV given 2 attempts or 90 seconds. If IV is unsuccessful, IO will attempt at the Primary site (proximal tibia). If IO is unsuccessful at scene, 2nd attempt can be done in the ambulance. Adrenaline will be delivered as according to protocol.

Device: Intraosseous

Intravenous

EXPERIMENTAL

Intravenous fluids or medications needed and a peripheral IV given 2 attempts or 90 seconds. If 1st IV is unsuccessful at scene, 2nd IV attempt can be done in the ambulance. Adrenaline will be delivered according to protocol.

Device: Intravenous

Interventions

Also known as: EZIO
Intravenous and Intraosseous
Also known as: IV Cannula
Intravenous

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Cardiac arrest (medical or traumatic)
  • Intravenous fluids or medications needed

You may not qualify if:

  • Adult needle (weight ≥ 40 kg)
  • Paediatric needle (weight 3 - 39 kg)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Singapore Civil Defence Force

Singapore, Singapore

Location

MeSH Terms

Conditions

Heart Arrest

Interventions

Cannula

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

CathetersEquipment and Supplies

Study Officials

  • Kenneth Boon Kiat Tan, MBBS

    Singapore General Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 11, 2014

First Posted

March 17, 2014

Study Start

June 1, 2014

Primary Completion

January 1, 2017

Study Completion

June 1, 2017

Last Updated

October 28, 2019

Record last verified: 2019-10

Locations